BridgeBio Pharma (BBIO) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -$7.3 million.
- BridgeBio Pharma's Other Gross PP&E Adjustments rose 29.09% to -$7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.2 million, marking a year-over-year increase of 53.26%. This contributed to the annual value of -$9.4 million for FY2024, which is 67.86% up from last year.
- Per BridgeBio Pharma's latest filing, its Other Gross PP&E Adjustments stood at -$7.3 million for Q3 2025, which was up 45.55% from -$13.3 million recorded in Q2 2025.
- Over the past 5 years, BridgeBio Pharma's Other Gross PP&E Adjustments peaked at -$7.3 million during Q3 2025, and registered a low of -$29.5 million during Q1 2024.
- For the 3-year period, BridgeBio Pharma's Other Gross PP&E Adjustments averaged around -$14.7 million, with its median value being -$13.3 million (2025).
- Per our database at Business Quant, BridgeBio Pharma's Other Gross PP&E Adjustments slumped by 102.50% in 2024 and then skyrocketed by 68.88% in 2025.
- Quarterly analysis of 5 years shows BridgeBio Pharma's Other Gross PP&E Adjustments stood at -$26.1 million in 2021, then declined by 2.57% to -$26.8 million in 2022, then dropped by 9.53% to -$29.4 million in 2023, then surged by 67.86% to -$9.4 million in 2024, then increased by 29.09% to -$7.3 million in 2025.
- Its Other Gross PP&E Adjustments was -$7.3 million in Q3 2025, compared to -$13.3 million in Q2 2025 and -$9.2 million in Q1 2025.